OPDIVO 10 mg/mL concentrate for solution for infusion., TIVOZANIB, TIVOZANIB
AV-951-20-304
Phase 3 small_molecule active
Quick answer
OPDIVO 10 mg/mL concentrate for solution for infusion., TIVOZANIB, TIVOZANIB for Renal cell carcinoma is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Renal cell carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active